Loading company…
Spiration developed a valve system to treat severe emphysema and improve lung function.
Spiration developed the Spiration® Valve System, a minimally invasive treatment for severe emphysema and Alpha-1 Antitrypsin Deficiency. It serves healthcare providers and pulmonologists in the United States and select European markets. Founded in 1999, the company was based in Redmond, US. Olympus Corporation acquired it in June 2010.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in